Zhang GM et al. |
[Population pharmacokinetics of tacrolimus in Chinese renal transplant patients]. |
2008 |
Yao Xue Xue Bao |
pmid:18819472
|
Wang M et al. |
Studies on the effects of the immunosuppressant FK-506 on the high-risk corneal graft rejection. |
2002 |
Yan Ke Xue Bao |
pmid:15510746
|
Li S et al. |
Experiment study of retinal ultrastructure after intravitreal FK506. |
2004 |
Yan Ke Xue Bao |
pmid:15124532
|
Xie H et al. |
Effect of topical FK506 used alone or combined with keratoplasty on patients with recurrent Mooren's corneal ulcer. |
2006 |
Yan Ke Xue Bao |
pmid:17378150
|
Ma H et al. |
[The effect of FK506 on the proliferation of HRCECs]. |
2006 |
Yan Ke Xue Bao |
pmid:17378157
|
Kagaya H et al. |
Quantification and 24-hour monitoring of mycophenolic acid by high-performance liquid chromatography in Japanese renal transplant recipients. |
2006 |
Yakugaku Zasshi |
pmid:17139160
|
Tayama Y et al. |
[Influence of tacrolimus and ciprofloxacin on glucose metabolism]. |
2007 |
Yakugaku Zasshi |
pmid:17978565
|
Naito T |
[Optimal immunosuppressive therapy based on pharmacokinetics and pharmacodynamics of antimetabolites in clinical practice]. |
2010 |
Yakugaku Zasshi |
pmid:21139397
|
Yamaguchi K et al. |
[Case of encephalopathy seemingly caused by tacrolimus at blood concentration near the upper limit of therapeutic range]. |
2012 |
Yakugaku Zasshi |
pmid:22790031
|
Nagao K et al. |
[Drug development from natural fermentation products: establishing a manufacturing process which maximizes the potential of microorganisms]. |
2010 |
Yakugaku Zasshi |
pmid:21048405
|
Fukudo M |
[Individualized dosage regimen of immunosuppressive drugs based on pharmacokinetic and pharmacodynamic analysis]. |
2007 |
Yakugaku Zasshi |
pmid:17603267
|
Sood S and Muthuraman A |
Activity of tacrolimus: an immunosuppressant, in pyloric ligation-induced peptic ulcer in the rat. |
2009 |
Yakugaku Zasshi |
pmid:19952532
|
Tanaka H et al. |
[Discovery and development of a novel immunosuppressant, tacrolimus hydrate]. |
1997 |
Yakugaku Zasshi |
pmid:9306728
|
Muraki Y |
[Factors affecting the pharmacokinetics after living donor liver transplant]. |
2012 |
Yakugaku Zasshi |
pmid:23023417
|
Iwamoto T et al. |
[Successful treatment by tacrolimus in two patients with Osserman's grade III intractable myasthenia gravis and elderly IIb]. |
2004 |
Yakugaku Zasshi |
pmid:15067188
|
Uchida K et al. |
Pharmacokinetics of orally administered tacrolimus in lupus nephritis patients. |
2010 |
Yakugaku Zasshi |
pmid:20046074
|
Niwa T et al. |
Effect of cyclosporine and tacrolimus on cytochrome p450 activities in human liver microsomes. |
2007 |
Yakugaku Zasshi |
pmid:17202802
|
Shimizu K |
Development of New Liposome Targeting Strategies for Application of Disease Therapies. |
2017 |
Yakugaku Zasshi |
pmid:28049894
|
Tanaka Y et al. |
[Effect of tacrolimus on the pharmacokinetics and glucuronidation of SN-38, an active metabolite of irinotecan]. |
2013 |
Yakugaku Zasshi |
pmid:23328499
|
Pan ZX et al. |
[IL-18 expression in whole blood cell cultures from active lupus nephritis and the inhibitory effects of FK506, cyclosporin A and dexamethasone]. |
2004 |
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi |
pmid:15555450
|